Christine Sagan
Family · Anchorage, AKNPI 1891988069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2023 at $1,166 and has fallen 54.7% since, to $529 in 2025. Among family clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$374
- Astellas Pharma US Inc$223
- AstraZeneca$190
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$162
- plus $885 from 18 others
What the payments were for
- Food & beverage$3,89395%
- Education$1985%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,157 |
| Novo Nordisk | 39 | $1,100 |
| Lilly USA, LLC | 13 | $374 |
| Astellas Pharma US Inc | 4 | $223 |
| AstraZeneca | 10 | $190 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $162 |
| Pfizer | 8 | $155 |
| Abbott | 2 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $105 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $61 |
| IBSA Pharma Inc. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $59 |
| QOL Medical, LLC | 2 | $43 |
| Radius Health, Inc. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $20 |
| GSK | 1 | $19 |
| Sandoz | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$251
- UBRELVY$150
- RYBELSUS$125
- MOUNJARO$124
- FREESTYLE LIBRE 3$124
How this compares
$4,091 in reported general payments places this provider in the 90th percentile of 315 family providers in Alaska.
Other family in Anchorage
- Erica HeagyAnchorage$249K
- Trisha KernodleAnchorage$60K
- Marisha DietersAnchorage$6K
- Christine HooverAnchorage$6K
- Leigh KeeferAnchorage$5K
- Sara GeraciAnchorage$4K
- Bethany BuchananAnchorage$4K
- Natasha SherrillAnchorage$4K
- Katherine HardyAnchorage$3K
- Andrea BirchAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.